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Canine parvovirus (CPV) suddenly appeared in the late 1970s after which it showed continuous antigenic changes. Virological
and molecular genetic analyses mainly focused on feline panleukopenia virus (FPLV) were conducted in this study because FPLV
is the suspected ancestor of CPV; the way in which FPLV evolves may help to explain the emergence of CPV. Analysis of escape
mutants against FPLV-specific monoclonal antibody showed that viruses possessing CPV-like properties were not easily detected
in FPLV virus stocks. Phylogenetic analysis revealed that the nonstructural protein 1 (NS1) and capsid protein 2 (VP2) genes of
FPLV changed with time. A similar tendency, however, was not observed in the FPLV VP2 proteins. In contrast, the topology of the
phylogenetic tree of VP2 proteins of CPV basically concurred with that of the VP2 genes. Analysis of the ratio of nonsynonymous
and synonymous substitutions revealed that synonymous substitutions exceeded nonsynonymous substitutions in both the NS1
and VP2 genes of FPLV, even when the analysis focused on specific regions in the VP2 gene that are known to be located on the
capsid surface. Comparison of the CPV VP2 genes revealed that nonsynonymous substitution was found to dominate over
synonymous substitution in one specific region in the VP2 gene. These results suggested that FPLV has changed mainly by random
genetic drift. In contrast, after the appearance of CPV, changes in the CPV VP2 gene appear to be partly selected by certain positive
selection forces. CPV and FPLV are known to be closely related viruses genetically and biologically, but the evolutionary
mechanisms of the two viruses appeared to be different. © 1998 Academic Press
INTRODUCTION
The emergence of canine parvovirus (CPV), a patho-
gen for dogs, was first observed in 1978 (Parrish, 1990).
The original CPV strain, CPV-type 2 (CPV-2), underwent
extensive antigenic changes and has been fully replaced
by the newer antigenic type strains, CPV-2a and CPV-2b
(Parrish et al., 1991). Retrospective serological studies
showed that no anti-CPV antibodies were detected in the
sera of domestic dogs or wild canine populations until
the mid-1970s, indicating that CPV is a comparatively
new pathogen for dogs (Schwers et al., 1979; Koptopou-
los et al., 1986). Although the conclusive origin of CPV is
unknown, the most widely accepted hypothesis for its
emergence is that CPV is derived from feline panleuko-
penia virus (FPLV) or other FPLV-like viruses by natural
genetic mutations.
CPV, FPLV, and mink enteritis virus (MEV) are clas-
sified as host range variants of feline parvoviruses
belonging to the genus Parvovirus in the family Parvo-
viridae (Siegl et al., 1985). FPLV, MEV, and a parvovirus
isolated from blue fox (BFPV) are indistinguishable
from each other by biological properties in vitro
(Tratschin et al., 1982; Veijalainen, 1988), but are dis-
tinguished by the host from which they were isolated.
In this study, therefore, we call the viruses isolated
from cats as FPLV, and the parvoviruses isolated from
mink and blue fox with the same biological properties
as FPLV are referred to as FPLV-like viruses. CPV,
FPLV, and FPLV-like viruses are more than 98% similar
in nucleotide and amino-acid sequences (Kariatsumari
et al., 1991), though CPV can be distinguished from the
others by biological properties. In addition to differ-
ences in their host ranges, these viruses have differ-
ent pH dependencies for hemagglutination (HA) (Car-
michael et al., 1980; Parrish et al., 1988a), and their
antigenicities are distinguishable by monoclonal anti-
bodies (MAbs) (Parrish et al., 1982; Parrish and Car-
michael, 1983; Veijalainen, 1988; Horiuchi et al., 1997).
CPV can replicate in cultured canine cells, while FPLV
and FPLV-like viruses either cannot replicate or repli-
cate inefficiently in the cultured canine cells (Tratshin
et al., 1982; Parrish and Carmichael, 1983; Mochizuki
and Hashimoto, 1986; Horiuchi et al., 1992; Truyen and
Parrish, 1992). Host range in vivo seems to be more
complex; FPLV can replicate in feline tissue and in
canine thymus but not in other canine tissues. CPV-2
cannot replicate in feline tissues, although antigenic
type variants CPV-2a and 2b are reported to replicate
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in ileum and lymphoid tissues of cats (Truyen and
Parrish, 1992; Truyen et al., 1994, 1996).
The introduction of a virus into a new host species
may happen in any number of ways: by genetic alter-
ation of the virus through point mutation, recombina-
tion, or gene reassortment or by changes in the ecol-
ogies around the hosts and the viruses (Kilbourne,
1991). CPV is thought to have emerged suddenly in
dogs (Parrish, 1990). CPV isolates appear to have
evolved from a single common ancestor (Truyen et al.,
1995) indicating that the introduction of FPLV or FPLV-
like viruses (i.e., an ancestral virus of CPV) into the
dog population has probably been a single event. For
instance, however, an interspecies transmission of
influenza A virus is reported to be a frequent event
(Kawaoka et al., 1989; Gorman et al., 1991). Perhaps
FPLV and FPLV-like virus populations may give rise to
another precursor of CPV, further change of which may
result in a second CPV epidemic. The anticipation of
probable outbreak of a new CPV is important to pre-
vent the suffering of animals from a new pathogen.
Elucidation of how FPLV and FPLV-like viruses evolve
may aid in assessing the likelihood of new CPV epi-
demics. After the appearance of CPV, its antigenicity
continuously changes by an antigenic drift type of
mechanism (Parrish et al., 1991). This type of continu-
ous antigenic change has not been reported for FPLV
and FPLV-like viruses, although some antigenic varia-
tion is reported among FPLV (Parrish et al., 1983;
Mochizuki et al., 1989). MEV isolates are reported to
be divided into three antigenic types when they are
analyzed with MAbs, although they coexist in mink
population (Parrish et al., 1984). Recently we reported
that restriction fragment length polymorphism analysis
of PCR products reveals genetic changes in FPLV
isolates over time (Horiuchi et al., 1996). This finding
led us to conduct more precise genetic and phyloge-
netic analyses of FPLV and FPLV-like viruses in an
attempt to uncover an evolutionary pattern in FPLV
variation.
Parvoviruses contain a linear ssDNA genome of
about 5 kb. The genome has two open reading frames
(ORF): a left-hand ORF encodes at least one nonstruc-
tural protein (NS1), and a right-hand ORF encodes the
two capsid proteins, VP1 and VP2, which are trans-
lated from alternatively spliced mRNA. Defining the
evolution of different genes among the same group of
viruses helps to clarify their phylogenetic relationships
more precisely. For this reason, we analyzed both the
NS1 and VP2 genes.
Our aim in this study is to make clear the following
questions: (1) Do FPLV virus populations have the
potential to generate precursor viruses that have in-
fectivity in dogs? (2) Is there any relationship between
the evolutionary pathway of FPLV and the appearance
of CPV? (3) What is the difference between the evolu-
tionary patterns of CPV and FPLV? To address these
questions, we analyzed mutants selected by escape
from FPLV-specific monoclonal antibodies and esti-
mated an evolutionary pattern for FPLV and FPLV-like
viruses.
RESULTS
Characterization of MAb-selected escape mutants
Recently we produced MAb P2–215, which recog-
nizes a specific epitope of FPLV and FPLV-like viruses
that includes aa93-Lys in VP2 (Horiuchi et al., 1997).
One of the critical amino acids that influences the host
range and antigenicity of CPV is aa93 (Chang et al.,
1992). Thus we analyzed the escape mutants selected
by MAb P2–215. Direct infectious center assays re-
vealed variant viruses that were not neutralized by
MAb P2–215 but that were present in the original FPLV
virus stocks, and the proportion of the presence of
variant viruses varied from 2.2 3 1024 to 2.3 3 1025
(Table 1).
Properties of the escape mutants are summarized in
Table 1. In enzyme-linked immunosorbent assay
(ELISA), all the escape mutants reacted with MAb
X1–251, the antibody that recognizes both CPV and
FPLV, but they did not react with FPLV-specific MAb
P2–215, indicating that the escape mutants lacked the
FPLV-specific epitope. However, the in vitro host
ranges of the escape mutants were the same as the
parent viruses, i.e., none of the escape mutants could
be propagated in A72 or Cf2Th canine cells. Because
parvoviruses are difficult to clone by plaque purifica-
tion, replicative form (RF) DNA was recovered from
virus-infected cells, cloned into plasmid, and consid-
ered representative of plaque purified virus. The VP2-
gene nucleotide sequences from two independent
plasmids of each escape mutant were viewed as char-
acteristic nucleotide sequences for each escape mu-
tant. With the exception of escape mutant TU4 (TU4-
es), the mutants had one nucleotide substitution at
nt671; this was a change of a G to an A caused by an
amino-acid change at aa224 from Gly to Glu. In addi-
tion to this substitution, TU4-es had another nucleo-
tide substitution at nt694 which resulted in an amino
acid change at aa232 from Val to Ile (Table 1). This
means that variant viruses with aa224 as Glu predom-
inated in the FPLV virus stocks and that substitution at
aa224 from Gly to Glu affected the epitope recognized
by MAb P2–215. A specific amino-acid substitution at
aa93 from Lys, which is characteristic of FPLV and
FPLV-like viruses, to CPV-specific Asn affected the
epitope’s recognition by MAb P2–215 (Horiuchi et al.,
1997); although the analysis in the present study was
based on only 12 clones, no escape mutants with
aa93-Asn were found in any FPLV virus stocks. In CPV,
VP2 aa93 and 224 are included in one CPV-specific
epitope (Strassheim et al., 1994). The same position in
FPLV VP2 seems to make up the FPLV-specific con-
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formational epitope, which is involved in virus neutral-
ization.
Nucleotide sequence analysis
For estimation of viral phylogenetic relationships, anal-
ysis of several genes from the same isolates usually
gives us more confident results. For this purpose, we
determined the nucleotide sequences of the NS1 and
VP2 genes from one FPLV vaccine strain originally iso-
lated in France and from 12 FPLV isolates that had been
collected in Japan between 1974 and 1995. Nucleotide
sequences of both the NS1 and VP2 genes were already
available for seven viruses in the feline parvovirus sub-
group. Those combined with newer isolates yielded the
20 nucleotide sequences of the NS1 and VP2 genes that
were the basis for our analysis.
The alignments of 20 NS1-gene sequences and 23
VP2-gene sequences are shown in Fig. 1, and the
characterization of the nucleotide substitutions in
those sequences are summarized in Table 2. When all
the changes were assigned for comparison, synony-
mous substitutions predominated over nonsynony-
mous substitutions for both genes in each virus. Al-
though the proportion of nonsynonymous substitutions
increased when only the phylogenetically informative
changes were compared, synonymous substitutions
were still more than the nonsynonymous substitutions.
Comparison of the NS1 and VP2 genes in FPLV and
FPLV-like viruses did not show any significant differ-
ence in the proportion of nonsynonymous substitu-
tions.
The VP1 and VP2 genes of FPLV and FPLV-like viruses
are well characterized (Parrish et al., 1988a; Truyen et al.,
1995), in contrast, little data are available for the NS1
gene. Comparison of the NS1-gene sequences of 16
FPLV and FPLV-like viruses with those from four CPV
isolates revealed five nucleotide changes that were spe-
cific for CPV (Fig. 1A). Three of these resulted in amino-
acid substitutions [nt741-NS1 (aa247), nt743-NS1 (aa248),
and nt1785-NS1 (aa595)], and the others were silent
(nt1224 and 1479-NS1).
Phylogenetic relationship
To analyze the phylogenetic relationships of the viral
isolates, we constructed phylogenetic trees by using a
branch-and-bound algorithm. To reduce the time
needed for computer analysis, instead of full-length
viral sequences, we used the nucleotide sequences of
the VP2 and NS1 genes, as aligned in Fig. 1. Repre-
sentative minimal trees for each gene and each pro-
tein are shown in Figs. 2 and 3. For NS1 genes, VP2
genes and VP2 proteins, more than 50 minimal trees
were obtained by branch-and-bound algorithm; how-
ever, the differences among those trees in each gene
and protein seemed not to be significant. Here, we
selected the minimal trees showing the same topology
as those obtained by neighbor-joining method as rep-
resentative trees. For NS1 proteins, 19 minimal trees
were obtained by branch-and-bound algorithm, and
those were classified into two group on the basis of
their topology (data not shown). So, we considered the
minimal tree showing the same topology as that ob-
tained by neighbor-joining method as representative
minimal tree for NS1 proteins.
The phylogenetic tree of the FPLV-NS1 genes
showed two branches with high confidence values
(.70%) (Fig. 2A). One of the two groups consisted of
four recent FPLV isolates that were isolated in the
1990s in Japan: 483, 94–1, Som1, and Som4. In the
phylogenetic tree of the FPLV-VP2 genes, the same
four isolates also constituted one group with a high
confidence level (Fig 3A), and this group was located
at the furthest position from the fiducial node in the
phylogenetic trees for each gene. These results indi-
TABLE 1
Incidence, Antigenic, Biological, and Genetic Properties of P2-215 Escape Mutants
Mutant Incidencea
Reactivity against
MAbs in ELISA
(A405nm)b Replication
in canine
cellsc
Nucleotide and amino acid changes in VP2
(Parent virus 3 Mutant virus)
P2-215 X1-251 Nucleotide Amino acid
TU2-es 7.9 3 1025 0.022 1.086 — nt671:G3A aa224:Gly3Glu
TU4-es 1.0 3 1024 0.009 0.971 — nt671:G3A aa224:Gly3Glu
nt694:G3A aa232:Val3 Ile
TU8-es 2.3 3 1025 0.011 1.102 — nt671:G3A aa224:Gly3Glu
TU10-es 1.9 3 1024 0.005 1.087 — nt671:G3A aa224:Gly3Glu
TU12-es 2.2 3 1024 0.009 1.026 — nt671:G3A aa224:Gly3Glu
FPV-483-es 9.1 3 1025 0.012 1.074 — nt671:G3A aa224:Gly3Glu
a Calculated by dividing the number of infectious center in the presence of MAb P2-215 by that of in the presence of negative control MAb (BSPX-54).
b Cut off value was 0.063.
c Determined by Southern blot analysis.
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FIG. 1. Nucleotide sequences of NS1 genes from 20 viruses (A) and those of VP2 genes from 23 viruses (B). Differing nucleotides are indicated by a letter.
The nucleotides that are identical to FPLV-b are indicated as dashes, while the nucleotides that differed from FPLV-b are indicated. Nucleotide positions in
the NS1 and VP2 genes are numbered above the sequence from adenine of the initiation codon of each gene with the corresponding genomic positions
in parentheses (nucleotide numbering followed the nucleotide sequence of MEV-Abashiri). Nucleotide changes that result in amino-acid substitutions are
indicated with amino-acid positions of each protein and deduced amino acid changes [amino acid in FPLV-b to that in other virus(es)].
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cated that both the NS1 and VP2 genes of FPLV varied
with time. However, phylogenetic trees of the NS1 and
VP2 genes also showed that isolates, AO1 and Fuka-
gawa, which were isolated recently in 1994 and 1993,
respectively, were closer to the older isolates than the
four above-mentioned isolates (Figs. 2A and 3A).
These data suggest that different genetic types of
FPLV coexist in cat populations, at least in Japan.
Unlike the phylogenetic tree of their VP2 genes, the
internal branches of the FPLV and FPLV-like virus
lineages were not present in the phylogenetic tree of
the VP2 proteins (Fig. 3), indicating that the branches
of the phylogenetic tree of the VP2 genes are mainly
composed of silent changes. In contrast, the topology
of the phylogenetic tree of CPV VP2 proteins is similar
to that of the VP2 genes. This suggested that the
continuous antigenic type change that is well known in
CPV is not present in FPLV, although several amino
acid variations are found.
Relationship between the nucleotide difference and
time of isolation
Porcine parvovirus (PPV) is reported to be the closest
virus to the feline parvovirus subgroup (Chapman and
Rossmann, 1993). We did not use PPV as a reference
virus because of numerous sequence gaps that made
aligning its nucleotide sequence with that of FPLV diffi-
cult. Instead, to estimate the evolutionary rate, we tenta-
tively assigned the fiducial node for CPV and FPLV sep-
arately (as indicated in Figs. 2A and 3A), on the basis of
the topology of the trees; the node under which all the
FPLV or CPV isolates are located was used as a fiducial
node for calculation of the number of substitutions in
each virus lineage.
From the slope of regression curve (Fig. 4), the evolu-
tionary rates of the NS1 and VP2 genes of FPLV were
estimated to be 9.2 3 1025 and 1.1 3 1024 nt/site/year,
respectively. The evolutionary rate of the FPLV VP2 gene
looked a bit lower than that of CPV (1.69 3 1024 nt/site/
year) (Parrish et al., 1991). When the graph was plotted
with the isolation year against the number of amino-acid
substitutions, the regression coefficient was 20.007 for
the VP2 proteins.
Ratio of synonymous and nonsynonymous
substitutions
To investigate the mechanism for the evolutionary
change of FPLV and CPV, ratio of synonymous substitu-
tions (dS) and nonsynonymous substitutions (dN) were
estimated. In the case of no selection, dS and dN would
be expected to be more or less the same. If certain
amino acids were conserved by purified selection (con-
servation for functions), dN would be expected to be
lower than dS. If positive selection was responsible for
the variation of the gene, then dN would be higher than
dS because such selection will accelerate amino acid
changes. In the phylogenetic tree of the VP2 genes,
CPV-d and FPLV-Obihiro were found to be the viruses
that corresponded most closely to the fiducial node, so
that dS and dN were calculated by comparison of CPV-d
with other CPV isolates or by comparison of FPLV-
Obihiro with other FPLV-isolates.
When whole nucleotide sequences of the NS1 gene
were used for analysis, dS always predominated over the
corresponding dN, and the ratios of dN to dS (dN/dS)
were nearly 0.1 both among CPV or FPLV (Table 3). As
with the VP2 gene, dS were still higher than the corre-
sponding dN, however, the ratio of dN:dS among CPV
was higher than that among FPLV. So we focused two
regions within VP2 on the basis of the three-dimensional
structure of the virion and the location of known amino-
acid variations. One is Region 1, ranging from aa80 to 106
in VP2 (nt238 to 318 in VP2 gene); there is three CPV vs
FPLV-specific amino acids within Region 1 (aa80, 93, and
103). The other is Region 2 ranging from aa295 to aa444
in VP2 (nt883 to 1332 in VP2 gene); there is one CPV vs
FPLV-specific amino acid (aa323), two intra-CPV specific
changes (aa300 and 305), and some linear B-cell
epitopes within Region 2 (Tsao et al., 1991; Agbandje et
al., 1993; Langeveld et al., 1993). Both regions are known
TABLE 2
Number of Sites Where Nucleotide Substitutions Were Observed
Viruses compared Assigned change
Substitutions in NS1 gene Substitutions in VP2 gene
Synonymous Nonsynonymous Synonymous Nonsynonymous
All 20 virusesa All 35 (0.67)d 17 (0.33) 32 (0.63) 19 (0.37)
Phylo. infor.c 15 (0.58) 11 (0.42) 15 (0.54) 13 (0.46)
FPLV and FPLV-likeb All 26 (0.70) 11 (0.30) 23 (0.79) 6 (0.21)
Phylo. infor. 11 (0.65) 6 (0.35) 9 (0.69) 4 (0.31)
a Twenty viruses with both NS1 and VP2 gene sequences available were used for comparison.
b A total of 16 FPLV and MEV viruses with both NS1 and VP2 gene sequences available were used for comparison.
c Phylogenetically informative nucleotide substitution.
d Number of sites where nucleotide substitutions were observed. Numbers in parentheses mean the ratio of the corresponding mutations to the
total substitutions in each gene.
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FIG. 2. (A) Phylogenetic tree constructed from the NS1-gene nucleotide sequences of 20 isolates. A representative of the shortest trees derived
by the branch-and-bound analysis is shown. Italics indicate number of nucleotide differences in each branch. The significance of the branching order
was assessed by bootstrap resampling of 100 replicates. Resulting values of more than 70% are indicated on each branch (in parentheses). Open
and closed circles on the FPLV and CPV lineages, respectively, indicate the fiducial node from which the nucleotide substitutions were counted for
each isolate to calculate the evolutionary rates. (B) Phylogenetic tree constructed from the NS1-amino acid sequences of 20 isolates. A representative
of the shortest trees derived by the branch-and-bound analysis is shown. Italics indicate number of amino acid differences in each branch. The
significance of the branching order was assessed by bootstrap resampling of 100 replicates.
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to form the 22 Å long spike of the capsid surface on the
threefold axes (Tsao et al., 1991; Agbandje et al., 1993).
The difference between CPV and FPLV became apparent
when the analysis was focused to these two regions
(Table 3). In Region 1, the dN was almost equal to the dS
among CPV, while the dN was obviously lower than the
dS among FPLV. For Region 2, the dN was higher than
the dS (dN/dS 5 2.42) among CPV, whereas the dN was
lower than the dS among FPLV.
DISCUSSION
Evolutionary patterns of CPV and FPLV
In a way similar to antigenic drift of influenza A viruses
in humans and horses (Webster et al., 1992), CPV-2, the
original CPV type, emerged in 1978 and has been re-
placed by newer antigenic types, CPV-2a and CPV-2b
(Parrish et al., 1985, 1988b, 1991; Senda et al., 1988). Here
we showed that, although they are closely related vi-
FIG. 3. (A) Phylogenetic tree constructed from the VP2-gene nucleotide sequences of 23 isolates. (B) Phylogenetic tree constructed from the VP2
amino-acid sequences of 23 isolates. The details are the same as in Fig. 2.
446 HORIUCHI ET AL.
ruses, the evolutionary pattern of FPLV differed from that
of CPV. The results presented here would support the
opinion that FPLV evolves with random genetic drift be-
cause of the following reasons.
Differences in phylogenetic trees
The phylogenetic analyses suggested that although
genetic variations in FPLV and FPLV-like viruses oc-
curred with time, VP2 antigenic type remained un-
changed. In contrast for CPV, the topology of the phylo-
genetic tree of the VP2 genes was basically the same as
that of its proteins. Among FPLV strains, few variations in
VP2 amino-acid sequences were consistent with the
results of the antigenic analyses with MAbs (Parrish et
al., 1983; Mochizuki et al., 1989). The relatively high
correlation coefficiency between the numbers of nucle-
otide substitutions and the year of isolation (Fig. 4) also
supported the idea that the FPLV VP2 genes have been
undergoing continuous genetic change for more than 20
years. For the VP2 proteins of FPLV, however, the slope of
the regression curve was 20.007 when the year of iso-
lation was plotted against the number of amino-acid
changes, indicating no continuous antigenic change.
Most of the FPLV isolates used here were isolated in
Japan, so we can say that FPLV changes by random
genetic drift at least in Japan. The evolution of the FPLV
genes are similar to those of the nucleoprotein (NP),
membrane proteins (M), and H3 hemagglutinin (HA)
genes of avian influenza A viruses (Gorman et al., 1990,
1991; Ito et al., 1991; Bean et al., 1992).
Evolutionary rates
Evolutionary rates of some viral surface antigens were
found to be faster than those of their internal antigens (Li
et al., 1988; Fitch et al., 1991; Webster et al., 1992). One
plausible explanation for this is that the surface antigen
changes faster to escape immune surveillance by the
host. The VP2 molecule of parvoviruses is a major com-
ponent of the capsid (Cotmore and Tattersall, 1987) and
thus VP2 may be subjected to selection pressure by
neutralizing antibodies of host immune systems. The
NS1 molecule, on the other hand, is not part of the capsid
and thus is not related to virus neutralization (Cotmore
and Tattersall, 1989). If the FPLV VP2 changes to escape
host immune surveillance, then VP2 might be thought to
change faster than NS1; however, the evolutionary rate
of FPLV VP2 proteins calculated from its regression sta-
FIG. 4. Estimation of the temporal rate of nucleotide variation in FPLV
NS1 (A) and VP2 (B) genes. Graphs were obtained by plotting the
number of nucleotide differences from the fiducial node against the
year of its isolation. The evolutionary rates are estimated by regression
of the year of isolation against the number of nucleotide differences
from the fiducial nodes (Figs. 2A and 2B). r, correlation coefficient, and
n, number of viruses plotted on the graph.
TABLE 3
Ratio of Nonsynonymous and Synonymous Substitutions
Viruses compared
VP2
NS1 (whole) VP2 (whole) Region 1 Region 2
dS dN dN/dS dS dN dN/dS dS dN dN/dS dS dN dN/dS
CPV-d vs. other CPVa 8.1 3 1023 8.4 3 1024 0.10 4.1 3 1023 3.2 3 1023 0.78 2.3 3 1022 2.5 3 1022 1.10 3.6 3 1023 8.8 3 1023 2.42
FPLV-Obb vs. other FPLVc 1.7 3 1022 1.6 3 1023 0.09 1.2 3 1022 1.3 3 1023 0.11 2.2 3 1022 6.8 3 1023 0.31 8.6 3 1023 5.5 3 1024 0.06
a n 54 for NS1, n 5 6 for VP2.
b FPLV-Obihiro.
c n 5 15.
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tistics (20.007) was considered to be zero. This indi-
cated that the positive selections for capsid functions
including escape from immune pressure may not be the
driving force of the FPLV evolutionary pathway.
dN and dS analysis
One of the striking differences between the evolution-
ary patterns of CPV and FPLV became obvious from the
results of dN and dS analysis (Table 3). The dS was
higher than dN when the entire NS1 and VP2 genes were
compared among CPV or FPLV. Among CPV, however, dN
was found to be higher than the dS when the comparison
was focused on the Region 2, which is exposed on the
surface of virion. When the entire gene regions are com-
pared, the effect of conservation of function may predom-
inate over that of positive selection, thereby leading to
the interpretation that the gene is changing in a way that
is consistent with the neutral theory of molecular evolu-
tion (Kimura, 1968), even though positive selection may
be operating at least on specific regions of the gene
(Gojobori et al., 1990, 1994). Overdominant selection is
found to operate on the antigen-recognition sites of ma-
jor histocompatibility complex class I and II molecules
on the basis of dN and dS analysis (Hughes and Nei,
1988, 1989). Furthermore, dN is also found to predomi-
nate over dS in the antigenic sites of some pathogens
which may be subjected to immune response (Ina and
Gojobori, 1994; Seibert et al., 1995; Endo et al., 1996),
indicating that positive selection operates on such spe-
cific sites of the genes. Therefore, the results of dN and
dS analysis suggested that positive selection may oper-
ate on at least one part of the VP2 gene of CPV in the
canine population, as suggested by Parrish et al. (1991),
although the real selection force remains to be deter-
mined. In contrast, no evidence for positive selection on
the VP2 proteins of FPLV was obtained; rather, those
seem to be in evolutionary stasis.
Comparison of evolution of FPLV with those of other
viruses
Influenza A viruses and primate lentiviruses also dis-
play different types of evolution based on the host (Web-
ster et al., 1992; Seibert et al., 1995). In the human
immunodeficiency virus type 1 (HIV-1) that causes AIDS,
the V3 loop of the envelope glycoprotein (gp120) is as-
sociated with various virus properties such as virus neu-
tralization, cell tropism, and receptor recognition (Mc-
Keating, 1996). Rates of amino acid changes in the V3
loop of HIV-1 are found to be significantly higher than
those of simian immunodeficiency virus from African
green monkeys (SIMAGM) (Shpaer and Mullins, 1993) that
is considered to be the oldest primate lentiviruses (John-
son et al., 1990) and avirulent for African green monkeys.
Influenza A virus of aquatic birds appears to be fully
adapted to waterfowls and is nonpathogenic to them.
Some of the virus proteins of avian influenza A virus have
remained unchanged for more than 50 years, while those
of human influenza A virus change rapidly (Webster et al.,
1992). In both cases, fewer amino-acid variations appear
in the viruses that are avirulent for their hosts. The
evolutionary pattern of FPLV genes appears to be similar
to those of influenza A virus of aquatic bird and SIVAGM;
however, FPLV is still pathogenic to felids. It is conceiv-
able that the relatively low level of amino-acid substitu-
tions in FPLV makes it difficult to elucidate the continu-
ous change of the VP2 proteins.
Parvoviruses are remarkably stable when exposed to
the environment, and their infectivity persists for a long
period in feces. Thus changes in the VP2 protein that
might help the virus escape immune surveillance may
not be necessary for the continued survival of the virus;
because the virus can survive in excreta without chang-
ing until its infects a naive host. Therefore, neutralizing
antibodies may not be a major selection force for the VP2
gene of CPV, as suggested for the evolution of some
other viruses by Wain-Hobson (1994). CPV has only a
short history in the dog in contrast to FPLV in cats. We
can hypothesize that CPV is undergoing changes that
will result in its ability to replicate more efficiently in the
dog. Support for this hypothesis lies in the finding that
the NP gene newly introduced into swine populations
evolved more rapidly than the classical NP gene of swine
influenza A virus (Gorman et al., 1991).
Implication of NS1 gene in host range
The VP2 gene affects the host range of parvoviruses
(Parrish et al., 1988a; Parrish, 1991; Chang et al., 1992;
Horiuchi et al., 1994); characterization of CPV/FPLV chi-
meric viruses revealed that aa93, 103, and 323 in VP2
determine the host range of CPV (Chang et al., 1992). In
addition, our study of CPV/MEV chimeras showed that
part of the NS1 gene contributes to the efficiency of virus
replication in canine cells (Horiuchi et al., 1994). Align-
ment of the NS1 genes from 20 isolates disclosed only
three amino-acid residues that were CPV specific. Of
those, aa595 is encoded within the region mentioned
above. Perhaps aa595 influences viral growth in certain
host cells.
How did CPV arise and how will new CPV arise?
Phylogenetic analyses of the CPV VP2 gene indicate
origination of CPV from a common ancestor (Truyen et
al., 1995). Our phylogenetic tree of the CPV NS1 gene
was consistent with that; all of the NS genes appeared to
originate from a common ancestor. FPLV appeared to be
in evolutionary stasis, which agrees with the idea that a
CPV ancestor arose from FPLV or an FPLV-like virus as a
result of random genetic mutations. However, this re-
mains to be confirmed as do any similarities between the
evolutionary patterns of FPLV-like viruses in each of their
host to that established for FPLV in the cat. BFPV is
suggested to be the closest virus to CPV on the basis of
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the phylogenetic relationship of VP2 genes (Truyen et al.,
1995). Based on the NS1 gene, MEV appeared to be the
closest virus to CPV (Fig. 2A). Some animals in the family
Canidae that are susceptible to FPLV-like viruses, such
as mink and blue fox, may play a role as reservoirs for
the ancestors of CPV.
Several interspecies transmissions of some genes of
influenza A virus from aquatic bird to humans, horses,
and swine are reported (Kawaoka et al., 1989; Gorman et
al., 1991). The considerable genetic diversity of the influ-
enza A virus of aquatic bird increases the chance for
production of a source of new genes that would have a
selective advantage in a particular host or altered cir-
cumstance (Gorman et al., 1992; Webster et al., 1992). We
attempted, without success, to find a virus in FPLV pop-
ulations that would have characteristics of CPV after
selection by escape from FPLV-specific MAbs. The evo-
lutionary rates of the FPLV genes is 10–100 times lower
than those of RNA viruses (Domingo and Holland, 1994).
Taken together with the proposal that accumulated mu-
tations may be required for the virus to acquire infectivity
in the dog (Chang et al., 1992), interspecies transmission
of the virus from cat to dog does not seem to take place
readily.
CPV-2a and 2b were recently isolated from cats man-
ifesting clinical signs of feline panleukopenia (Mochizuki
et al., 1996; Truyen et al., 1996). This may mean that CPV
and FPLV can infect host cells simultaneously, a situation
that might provide the opportunity for intermolecular re-
combination between the two viruses. Such an occur-
rence might confer expanded host range or altered
pathogenicity to the viruses. In some RNA viruses such
as alphavirus and coronavirus, intermolecular recombi-
nation drives the emergence of new pathogenic virus
(Hahn et al., 1988; Olsen, 1993). Thus monitoring of re-
cent isolates may be needed to anticipate and assess
the risk caused by such newly emerging viruses.
MATERIALS AND METHODS
Viruses, cells, and antibodies
The virus isolates used here are listed in Table 4.
Crandell feline kidney (CRFK) cells (Crandell et al., 1973)
and A72 canine fibroma cells (Binn et al., 1980) were
maintained as described previously (Horiuchi et al.,
1992). Anti-MEV rabbit serum and MAbs P2–215 and
X1–251 were used in this study. The MAb P2–215 recog-
nizes the FPLV and FPLV-like viruses-specific epitope
TABLE 4
Viruses Used Here
Virus
Year of
isolation
Place of
isolation
Passage
No.
Accession No.
Reference of sequencesNS VP2
FPLV
b 1967 U.S. UKa M38246 M38246 Parrish (1991)
PLI-IV 1968 France UK AB000057 D88287 This study
193 1970 Australia UK X55115 X55115 Martyn et al. (1990)
Obihiro 1974 Hokkaido*b .20 AB000055 AB000056 This study
TU2 1975 Tokyo* 16 AB000065 AB000066 This study
TU4 1975 Tokyo* 15 AB000067 AB000068 This study
TU8 1976–1977 Tokyo* 14 AB000069 AB000070 This study
TU10 1978–1980 Tokyo* 18 AB000062 D78584 This study
TU12 1978–1980 Tokyo* 15 AB000063 AB000064 This study
483 1990 Hokkaido* 2 AB000048 D88286 This study
Fukagawa 1993 Fukushima* 2 AB000053 AB000054 This study
94-1 1994 Tottori* 1 AB000049 AB000050 This study
AO1 1994 Hokkaido* 1 AB000051 AB000052 This study
Som1 1994 Nara* 1 AB000058 AB000059 This study
Som4 1995 Saitama* 1 AB000060 AB000061 This study
FPLV-like
MEV-Abashiri 1978 Hokkadio* .20 D00765 D00765 Kariatsumari et al. (1991)
BFPV 1983 Finland UK NAc U22185 Truyen et al. (1995)
CPV
Norden 1978 U.S. UK M19296 M19296 Reed et al. (1988)
d 1979 U.S. UK M38245 M38245 Parrish (1991)
Y1 1982 Tokyo* 7 D26079 D26079 Horiuchi et al. (1994)
31 1983 U.S. UK NA M24000 Truyen et al. (1995)
39 1984 U.S. UK NA M74849 Truyen et al. (1995)
15 1984 U.S. UK NA M24003 Truyen et al. (1995)
a Unknown.
b Asterisk means Japanese isolates (prefecture is indicated).
c Not available.
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that includes aa93-Lys and the MAb X1–251 reacts
equally with CPV and FPLV and FPLV-like viruses (Ho-
riuchi et al., 1997).
Selection of escape mutants
Virus stocks of field isolates of FPLV [approximately
106 plaque forming units (PFU)/100 ml] were incubated
with an equal volume of ascitic fluid (diluted 1:100) con-
taining MAb P2–215 for 1 h at room temperature (r.t.), and
used to inoculate CRFK cells. After absorption, the cells
were washed with medium, and growth medium contain-
ing 0.5% MAb P2–215-ascitic fluid was replaced. Blind
passage was repeated in the presence of MAb P2–215
until viral CPE was observed.
Infectious center assay
To estimate the proportion of variant viruses in the
original virus stocks, 100 ml of virus stock were incu-
bated with an equal volume of a 1:100 dilution of MAb
P2–215 ascites or negative control MAb BSPX-54 (Ho-
riuchi et al., 1995) for 1 h at r.t., and then viruses were
adsorbed to CRFK cells for 1 h at 37°C. After absorp-
tion, the cells were overlaid with growth medium con-
taining 1.2% methyl cellulose and 0.5% MAb P2–215-
ascites, and cultured for 5 days at 37°C. Staining of
infectious centers was carried out as described else-
where (Horiuchi et al., 1994).
Characterization of antigenicity
The antigenicity of the viruses was determined by
antibody-sandwich ELISA as described elsewhere (Ho-
riuchi et al., 1997).
In vitro host range analysis
The host range of the viruses was determined by the
ability of the viruses to replicate in canine cell lines, A72
canine fibroma cells and Cf2Th canine thymus cells.
Low-molecular-weight DNA was extracted from virus-
infected cells, and the presence of RF DNA was analyzed
by Southern blot. The details were described previously
(Horiuchi et al., 1992).
Preparation of virion DNA and cloning of RF DNA
Virion DNA used as a template for PCR was prepared
as described previously (Horiuchi et al., 1996). RF DNA
was recovered from virus-infected cells in two 100-mm
dishes. Extraction of RF DNA was carried out by a mod-
ified Hirt’s method as described previously (Horiuchi et
al., 1992). The RF DNA was digested with the restriction
enzyme BstI107 I and the resulting 4.3-kb fragment,
which corresponds to map units (m.u.) 6.4–93.3, was
cloned into the EcoRV site of the Bluescript SK1 vector
(Stratagene).
PCR and nucleotide sequence analysis
The sequences of primers used for PCR are described
below. The region from nt245 to 2371, which contains the
entire NS1 ORF (nt311 to 2314), was amplified by PCR in
three sections with three sets of primers: primers N1 and
N2, primers N3 and N4, and primers N5 and N6. The
region from nt2726 to 4759, which contains the entire
VP2 ORF (nt2825 to 4576), was amplified in five sections
with five sets of primers: primers V51 and V55, primers
V1 and V52, primers V5 and V9, primers V8 and V56, and
primers V22 and V41. Amplifications were done with
ExpandTM High-Fidelity System (Boehringer Mannheim).
The amplified fragments were purified through a S-300
HR spin column (Pharmacia) to remove the excess prim-
ers and then used for the direct sequencing of the PCR
product. To determine the nucleotide sequence of the
VP2 gene of the escape mutants, RF DNA cloned into the
plasmid vector was used as a template for the sequenc-
ing reaction. Nucleotide sequences were determined
with an automated DNA sequencer (ABI-373A, Applied
Biosystems) and ABI PRISM Dye Terminator Cycle Se-
quencing Reaction Kit (Applied Biosystems). The se-
quences were analyzed with GENETYX-MAC/CD soft-
ware (Software Development).
The sequences of primers are as follows: N1, 59-CATAG-
ACCGTTACTGACATTC-39 (nt 245–265); N2, 59-TATGTCTG-
TCTTGATACTTC-39 {nt 1033–1052 [complementary (comp)]};
N3 59-CATTTTGGAAATATGATAGCA-39 (nt 926–946); N4, 59-
ATTTGCTTAGTTCCTTTACCT-39 [nt 1720–1820 (compl)]; N5,
N59-AGCTGGTAACTTTGGTCAAC-39 (nt 1645–1664); N6, 59-
TACTAACACACCCTTACCTC-39 [nt 2352–2371 (comp)]; V1,
59-GTACATTTAAATATGCCAGA-39 (nt 3029–3048); V5, 59-
AGCTATGAGATCTGAGACA-39 (nt 3388–3406); V8, 59-AATA-
CAAACTATATTACTGAAG-39 (nt 3785–3806); V9, 59-TCCTG-
CTGGATATCTTCCT-39 [nt 4042–4060 (comp)]; V22, 59-TGT-
CAAAATAATTGTCCTG-39 (nt 4292–4310); V41, 59-ATTGTAT-
ACCATATAACAAACC-39 [nt 4738–4759 comp)]; V51, 59-
CCAACTAAAAGAAGTAAACC-39 (nt 2726–2745); V52, 59-AT-
TAATGTTCTATCCCATTG-39 [nt 3461–3480 (comp)]; V55, 59-
ACTAACTAAATGCAACTCAC-39 [nt 3224–3243 (comp)]; V56,
59-AATTGGATTCCAAGTATGAG-39 [nt 4449–4468 (comp)].
Molecular evolutional analysis
The phylogenetic relationship was analyzed by using
the branch-and-bound algorithm of the PAUP (phyloge-
netic analysis using parsimony) package version 3.1.1
(Swofford, 1993). Evolutionary rates for NS1 and VP2
genes were estimated from the regression of the year of
isolation against the number of differences between
each isolate and the internal node that were tentatively
assigned as a fiducial point (indicated in Figs. 2 and 3).
Programs from the PHYLIP (Phylogeny inference pack-
age) version 3.5c (Felsenstein, 1993) were also used to
infer the phylogenetic tree; pairwise genetic distances
were calculated by using the DNADIST program under
Kimura’s two-parameter model, and phylogenetic trees
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were constructed by the neighbor-joining method by us-
ing the NEIGHBOR program. A bootstrap analysis with
100 replicates was done to assess the confidence level
of the branch pattern. A value of .70% is considered
significant (Hills and Bull, 1993).
The ratio of synonymous (dS) and nonsynonymous
(dN) substitutions were estimated by Nei and Gojobori’s
method (Nei and Gojobori, 1986).
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